CRP and neoplasm: ESR and CRP were the most commonly performed laboratory tests to estimate disease improvement or aggravation, and combining tumour M2-PK with these tests in the ROC curve analysis for the discrimination of disease severity showed an excellent performance, with an AUC which was higher than that of ESR and CRP alone; this implies that it could have an additional clinical value in measuring RA activity.